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Acne is a multifactorial disease which begins to be visible when some pilosebaceous ducts become 
plugged with keratinocytes ultimately forming comedones. The ductal hypercornification can result from 
hyperproliferation of ductal keratinocytes or reduced separation of ductal corneocytes. Cells of the acne 
ductal hypercornification have more desmosomes and tonofilaments than is normal [1]. Instead of 
sloughing off in the normal fashion, ductal corneocytes remain cohesive. They eventually occlude the 
follicular infundibulum with a cornified plug. Sebum is also abundant and entrapped in this enlarged 
follicular reservoir [2]. 
Sun exposure may interfere in the global pathogenesis of acne. Sebum production is often increased [3, 4], 
Propionibacterium acnes suffers from partial photodynamic destruction [5], and the process of 
desquamation is altered [6, 7]. In addition, ultraviolet light induces other diverse biological effects in the 
distal portion of exposed pilo-sebaceous follicles. Indeed, cytokines are released from comedones [4] and 
some neuromediators including melanocortins are also likely to be involved [8, 9]. Under such 
circumstances, some acne-prone individuals develop kerosis corresponding to horny plugs collected in the 
follicular acro-infundibulum. These concurrent effects are probably involved in acne aestivalis [10], and are 
 
possibly an initial step in the autumnal exacerbation of commedonal acne and acne vulgaris. 
2-hydroxy-5-octanoyl benzoic acid is also known as beta-lipohydroxyacid (LHA). This compound is primarily 
a potent "keratolytic" agent, cleaving the corneodesmosomes to release the excess of corneocytes in 
hyperkeratotic conditions [11-13]. It also exhibits boosting effects on keratinocytes and dermal dendrocytes 
somewhat mimicking those of all-trans-retinoic acid [12, 14-18]. The lipophilic properties of LHA allow 
maximum concentration inside the stratum corneum, particularly in the sebum-enriched infundibulum of 
pilosebaceous units. Thus, the compound is likely to be trapped in lesional sebaceous follicles which 
represent a critical therapeutic target in comedonal acne. The product has shown efficacy in preventing and 
treating mild acne [19]. 
Comedogenicity and comedolysis can be studied in animal models and in humans [20]. One of the novel 
and most rewarding methods relevant for acne assessment relies on image analysis of video images 
recorded under ultraviolet light illumination [21]. 
The aim of the present study was to assess non-invasively the capacity of a proprietary LHA formulation to 
clear the horny plugs accumulated in the acro-infundibulum during the summertime on the face of acne-
prone patients. 
Materials and method 
The protocol was approved by the local Ethics Committee. The comparative trial was performed in 
accordance with the Helsinki declaration and its subsequent revisions. The sample size was calculated to 
detect a difference in microcomedo density at the 5 % two-tailed significance with 80 % power. As we 
wanted to objectivate any comedolytic effect interfering with the natural history of acne over a short period of 
time, controls consisted of untreated skin rather than placebo-treated skin. 
A total of 28 untreated, acne-prone Caucasian women with photosensitive skin were enrolled in the study. 
They were aged 24 ±  3 years. They experienced for several years exacerbations of acne at the end of 
summertime. They were otherwise healthy. Upon return from sunny holidays, one group of 14 randomized 
volunteers received the LHA formulation (Effaclark®, Roche Posay) to be applied twice daily on the face for 
2 weeks. At that time of the year, the weather was cloudy in the Liège region. The other group of 
14 volunteers remained untreated. 
Due to the short study duration, the effect of treatment on inflammatory acne lesions was not considered. By 
contrast, tolerance was assessed by inquiring about stinging sensations and looking for erythema and 
desquamation. 
A video camera equipped with an internal ultraviolet illumination source (Visioscan®, C + K Electronic, 
Cologne, Germany) recorded the pattern of the skin surface aspect according to a previously described 
method [21-23]. Images were recorded from the mid forehead at inclusion and twice weekly during the 14-
day treatment phase. Kerosis was recognized as white tips located at the orifices of the pilosebaceous 
follicles. Pictures were recorded using a Sony video graphic printer UP-890CE ®. They were also digitalized 
in a 512 x 400 pixel frame. Image analysis of the area covered by kerosis was performed after a stepwise 
contrasting procedure followed by the holefill procedure 
The number, mean area and total area of the keratotic follicular plugs were recorded in each subject. 
Means and SD were calculated in both groups of volunteers. Variance analysis was performed in each 
group to compare data obtained in time. A p value lower than 0.05 was considered significant. 
Results 
At inclusion, cornified follicular plugs were clearly identified on the forehead in 12/14 volunteers enrolled in 
the LHA group and in 10/14 volunteers enrolled in the untreated group (Fig. 1). Only these volunteers were 
considered for further evaluations.  During the treatment period, the tolerance of the LHA formulation was 
excellent as no side-effect was reported or observed. Image analysis showed striking changes in the 
density of the follicular keratotic plugs. A remarkable comedolytic effect was evident in 10/12 LHA-treated 
patients (Fig. 2). A similar decline in the keratotic plug density was seen in only 3/10 untreated patients.  In 
the LHA-treated group, the density in keratotic follicular plugs decreased sharply during the 14-day 
treatment reaching significance (p < 0.001) from day 7 on (Fig. 3). The mean area of the keratotic follicular 
plugs was little influenced by the treatment (Fig. 4). The total area of these structures decreased 
significantly from day 7 (p < 0.05), and furthermore at days 10 and 14 (p < 0.001) (Fig. 5).  In the control 
untreated group, no significant changes in any of the evaluated morphometric parameters were yielded 
during the observation period. 
Discussion 
Many causes are probably involved in the pathogenesis of acne. Androgens, hyperactivity of the sebaceous 
gland, bacteria, genetics, drugs, occupation, and stressful episodes are well recognized causative or 
boosting factors. Environmental factors, including climate and ultraviolet light, are also presumed to be 
important in the provocation of acne [1, 6]. Hot and humid weather usually has a negative impact on acne. 
The effect of ultraviolet light is less obvious and more controversial. Some patients believe in the 
suppressive effect of sunlight on acne. The improvement may be caused by either the placebo effect or 
masking effect from sunlight tanning and erythema. By contrast, the effect of sunlight on acne is deleterious 
for some patients who complain from aggravation of acne lesions during summertime [10]. The 
mechanism probably primarily involves comedo formation. 
Broadly, topical acne therapy can be divided into anti-comedonal and anti-bacterial (anti-inflammatory) 
agents. The presently reported comedolytic effect can be ascribed to the global formulation of the tested 
proprietary cream. Hence, compounds other than LHA may also participate in the overall in vivo effect seen 
in acne-prone patients. LHA basically belongs to the family of keratolytic and comedolytic agents [3, 18-20]. 
Resolving micromedones also decreases the follicular bacterial load. Loosening intercorneocyte binding 
may also be associated with an alteration in bacterial adherence inside the follicular openings [19]. This 
mechanism is not at risk of inducing bacterial resistance to antimicrobials [24]. 
In the present study design, the comedolytic effect was specifically assessed on early formed 
micromedones presumably induced by intense ultraviolet light exposure. As experienced in the control 
untreated group such follicular changes may spontaneously clear in a small percentage of acne-prone 
subjects within a 2-week period. It is inferred that some of these follicular cornified plugs are loosely 
adherent to the acro-infundibulum. The fact that the number and total size of the cornified follicular plugs 
decreased during treatment while their mean size remained unchanged means that these structures were 
elimina  ted as single block units rather than progressively thinned. This effect was achieved by twice daily 
applications when sun exposure was limited. Indeed, photodegradation of LHA may occur and limits its 
efficacy. Under the trial circumstances, the tolerance of the LHA formulation was excellent. 
The proportion of the cornified follicular plugs turning to larger and adherent open comedones is unknown. 
When this process is prominent, microcomedonal acne should become manifest. In this acne progression 
pathway, the presently tested formulation is likely to be helpful in preventing seasonal outbreaks of acne. 
Once larger comedones are established, the efficacy of the LHA formulation is unknown compared to a 
topical retinoid such as adapalene [25, 26]. 
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